UY30555A1 - Formulacion aerosol para la inhalacion de beta-agonistas - Google Patents

Formulacion aerosol para la inhalacion de beta-agonistas

Info

Publication number
UY30555A1
UY30555A1 UY30555A UY30555A UY30555A1 UY 30555 A1 UY30555 A1 UY 30555A1 UY 30555 A UY30555 A UY 30555A UY 30555 A UY30555 A UY 30555A UY 30555 A1 UY30555 A1 UY 30555A1
Authority
UY
Uruguay
Prior art keywords
inhalation
aerosol formulation
agonists
beta
radicals
Prior art date
Application number
UY30555A
Other languages
English (en)
Inventor
Michael Nowak
Michael Aven
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38564599&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY30555(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of UY30555A1 publication Critical patent/UY30555A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Abstract

La presente invencion se refiere a una formulacion aerosol exenta de gas propulsor, para la inhalacion, la cual contiene uno o varios compuestos de la formula general 1 en la que los radicales R1, R2, R3 y X" pueden tener los significados mencionados en las reivindicaciones y en la descripcion.
UY30555A 2006-08-22 2007-08-21 Formulacion aerosol para la inhalacion de beta-agonistas UY30555A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06119274 2006-08-22

Publications (1)

Publication Number Publication Date
UY30555A1 true UY30555A1 (es) 2008-03-31

Family

ID=38564599

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30555A UY30555A1 (es) 2006-08-22 2007-08-21 Formulacion aerosol para la inhalacion de beta-agonistas

Country Status (9)

Country Link
US (1) US20080053430A1 (es)
EP (1) EP2056837A1 (es)
JP (1) JP2010501523A (es)
AR (1) AR062477A1 (es)
CA (1) CA2661442A1 (es)
PE (1) PE20080425A1 (es)
TW (1) TW200820974A (es)
UY (1) UY30555A1 (es)
WO (1) WO2008023005A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005008921A1 (de) * 2005-02-24 2006-08-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von Atemwegserkrankungen
US7423146B2 (en) * 2005-11-09 2008-09-09 Boehringer Ingelheim International Gmbh Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
UY30550A1 (es) * 2006-08-22 2008-03-31 Boehringer Ingelheim Int Nuevos beta-agonistas enantioméricamente puros, procedimientos para su preparacion y su uso como medicamentos
EP2093219A1 (de) 2008-02-22 2009-08-26 Boehringer Ingelheim International Gmbh Kristalline, enantiomerenreine Salzform eines Betamimetikums und dessen Verwendung als Arzneimittel
WO2010111398A2 (en) * 2009-03-24 2010-09-30 Chevron U.S.A. Inc. A system and method for characterizing fractures in a subsurface reservoir

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3026534A1 (de) * 1980-07-12 1982-03-18 C.H. Boehringer Sohn, 6507 Ingelheim 3,1-benzoxazin-2-one, ihre herstellung und verwendung
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
DE102005008921A1 (de) * 2005-02-24 2006-08-31 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von Atemwegserkrankungen
US7423146B2 (en) * 2005-11-09 2008-09-09 Boehringer Ingelheim International Gmbh Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
UY30550A1 (es) * 2006-08-22 2008-03-31 Boehringer Ingelheim Int Nuevos beta-agonistas enantioméricamente puros, procedimientos para su preparacion y su uso como medicamentos

Also Published As

Publication number Publication date
EP2056837A1 (de) 2009-05-13
PE20080425A1 (es) 2008-06-16
US20080053430A1 (en) 2008-03-06
WO2008023005A1 (de) 2008-02-28
JP2010501523A (ja) 2010-01-21
CA2661442A1 (en) 2008-02-28
AR062477A1 (es) 2008-11-12
TW200820974A (en) 2008-05-16

Similar Documents

Publication Publication Date Title
UY29844A1 (es) Formulación en aerosol para la inhalación de beta-agonistas
UY30542A1 (es) Formulacion de aerosol para la inhalacion de agonistas beta
UY30543A1 (es) Formulacion de aerosol para la inhalacion de beta- agonistas
CR8824A (es) Derivados de 2-carbamida-4-feniltiazol, su preparacion y su aplicacion en terapeutica
ECSP067004A (es) Formulación en aerosol para la inhalación de beta-agonistas
CO6160235A2 (es) Isoxazolinas insecticidas
WO2007148185A3 (en) Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors
AR047526A1 (es) Halogenoalquilcarboxamidas
CR11548A (es) Azolilmetiloxiranos, su uso y agentes que los contienen
CR11106A (es) Inhibidores de cinasa p710 s6
WO2007124092A3 (en) Photoacid generator compounds and compositions
ECSP066541A (es) Nuevos derivados de piridazin-3(2h)-ona
CO6280399A2 (es) Peptidil nitrilos y uso de los mismos como inhibidores de peptidil peptidasa i
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
CR8986A (es) Isoxazoles sustituidos como fungicidas
NO20091845L (no) Macrocykliske peptider som hepatitt C virus-inhibitorer
CR10479A (es) Modulares bencimidazolicos de vr1
PA8667201A1 (es) Nuevos compuestos farmaceuticos
UY31736A (es) Derivados sustituidos de pirazol y su uso
PA8846901A1 (es) Inhibidores de cinasa akt y p70 s6.
AR062211A1 (es) Derivados de 6-carboxi-normorfinano. composiciones farmaceuticas
HRP20080529T3 (en) Amide prodrug of gemcitabine, compositions and use thereof
ES2572001T3 (es) Derivado de bisfurano antivírico como inhibidor de la proteasa del VIH e intermedios del mismo
HN2008000088A (es) Heterociclicos de 1,4-dihidropiridina- fusionada, procesos para preparar los mismos, su uso y las composiciones que los contienen.
SG158091A1 (en) Imidazoazepinone compounds

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20170725